SCIACOVELLI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.049
EU - Europa 2.115
AS - Asia 2.038
AF - Africa 593
SA - Sud America 509
OC - Oceania 58
Continente sconosciuto - Info sul continente non disponibili 22
Totale 10.384
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.749
IT - Italia 942
SG - Singapore 720
CN - Cina 377
BR - Brasile 331
HK - Hong Kong 230
PL - Polonia 169
VN - Vietnam 139
DE - Germania 98
SE - Svezia 96
FI - Finlandia 94
RU - Federazione Russa 84
NL - Olanda 66
FR - Francia 65
GB - Regno Unito 55
AR - Argentina 37
ID - Indonesia 36
UA - Ucraina 34
MX - Messico 33
IN - India 31
CA - Canada 29
IQ - Iraq 26
JP - Giappone 26
MU - Mauritius 26
EC - Ecuador 25
TN - Tunisia 25
ZA - Sudafrica 25
ES - Italia 24
PT - Portogallo 23
RO - Romania 23
MA - Marocco 22
TR - Turchia 22
CI - Costa d'Avorio 21
GR - Grecia 21
AT - Austria 20
EG - Egitto 20
LC - Santa Lucia 20
NI - Nicaragua 20
PE - Perù 20
AO - Angola 19
ET - Etiopia 19
LA - Repubblica Popolare Democratica del Laos 19
MN - Mongolia 19
PH - Filippine 19
PS - Palestinian Territory 19
AE - Emirati Arabi Uniti 18
CG - Congo 18
HU - Ungheria 18
IE - Irlanda 18
UG - Uganda 18
YE - Yemen 18
BF - Burkina Faso 17
CU - Cuba 17
DZ - Algeria 17
GN - Guinea 17
NO - Norvegia 17
TZ - Tanzania 17
VE - Venezuela 17
ZW - Zimbabwe 17
AZ - Azerbaigian 16
BA - Bosnia-Erzegovina 16
DO - Repubblica Dominicana 16
GT - Guatemala 16
KE - Kenya 16
KG - Kirghizistan 16
KR - Corea 16
LU - Lussemburgo 16
LY - Libia 16
PA - Panama 16
RW - Ruanda 16
TH - Thailandia 16
UY - Uruguay 16
BJ - Benin 15
CH - Svizzera 15
IS - Islanda 15
LB - Libano 15
ME - Montenegro 15
MG - Madagascar 15
NC - Nuova Caledonia 15
PY - Paraguay 15
SK - Slovacchia (Repubblica Slovacca) 15
TJ - Tagikistan 15
ZM - Zambia 15
AL - Albania 14
AM - Armenia 14
BE - Belgio 14
BS - Bahamas 14
BZ - Belize 14
GE - Georgia 14
KZ - Kazakistan 14
MY - Malesia 14
NP - Nepal 14
PK - Pakistan 14
SA - Arabia Saudita 14
UZ - Uzbekistan 14
BY - Bielorussia 13
CL - Cile 13
CR - Costa Rica 13
CW - ???statistics.table.value.countryCode.CW??? 13
CZ - Repubblica Ceca 13
Totale 9.788
Salva come PNG Salva come JPEG
Città #
Fairfield 796
Woodbridge 484
Ashburn 463
Singapore 394
Houston 341
Ann Arbor 292
Cambridge 291
Chandler 270
Seattle 267
Wilmington 248
Hong Kong 217
Bytom 141
Beijing 107
Boardman 96
Princeton 92
Santa Clara 90
Milan 82
San Diego 80
Medford 63
Rome 52
Ho Chi Minh City 50
Los Angeles 49
Helsinki 48
Padova 45
Nanjing 43
Des Moines 42
Roxbury 41
Jacksonville 40
Chicago 25
São Paulo 24
Bologna 21
Hanoi 21
Castries 20
Florence 20
Jinan 20
Abidjan 19
Managua 19
Munich 18
New York 18
Vientiane 18
Conakry 17
Hebei 17
Kampala 17
Baku 16
Buffalo 16
Harare 16
Kigali 16
Ulan Bator 16
Dar es Salaam 15
Havana 15
London 15
Montevideo 15
Naples 15
Noumea 15
Panama City 15
Antananarivo 14
Dong Ket 14
Dublin 14
Frankfurt am Main 14
Lusaka 14
Nairobi 14
Nanchang 14
Shenyang 14
Amman 13
Cotonou 13
Dakar 13
Luanda 13
Luxembourg 13
Nassau 13
Ouagadougou 13
Trento 13
Warsaw 13
Bishkek 12
Dushanbe 12
Niamey 12
San José 12
Tashkent 12
Venezia 12
Bamako 11
Genoa 11
Kingstown 11
Phnom Penh 11
Pieve a Nievole 11
Rio de Janeiro 11
Banjul 10
Brasília 10
Bridgetown 10
Dallas 10
Dili 10
Guatemala City 10
Johannesburg 10
Lisbon 10
Maputo 10
Podgorica 10
Port Louis 10
Port Moresby 10
Reykjavik 10
Sanaa 10
Tbilisi 10
Tunis 10
Totale 6.230
Salva come PNG Salva come JPEG
Nome #
Indicatori di Qualità nei Point Of Care Testing (POCT): Sono efficaci? 530
“Modello di indicatori di qualità” dell’IFCC WG-LEPS: Risultati ed evoluzione del progetto. 526
Quality indicators to detect pre-analytical errors in laboratory testing 195
Harmonization of pre-analytical quality indicators. 187
What information on measurement uncertainty should be communicated to clinicians, and how? 180
A pilot study for establishing quality indicators in molecular diagnostics according to the IFCC WG-LEPS initiative: Preliminary findings in China 176
An Italian External Quality Assessment (EQA) program on urinary sediment. 173
Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity 173
Decision Support and Patient Safety 172
Performance criteria and quality indicators for the pre-analytical phase. 168
The pathway for introducing novel examination procedures in routine practice in accordance with ISO 15189:2012: 17-Hydroxy progesterone, dehydroepiandrosterone sulphate and vitamin D as examples 168
Assessment of package inserts for diagnostic kits. 168
An integrated system for monitoring the quality of sample transportation. 167
External Quality Assessment: an effective tool for Clinical Governance in Laboratory Medicine 166
High-performance liquid chromatography for cyclosporin measurement: comparison with radioimmunoassay 165
Validation model of a laboratory-developed method for the ISO15189 accreditation: The example of salivary cortisol determination 163
Analytical performances of a chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG and antibody kinetics 159
Extra-analytical sources of uncertainty: which ones really matter? 158
A rapid, specific enzyme immunoassay for follitropin and lutropin determination. 154
Measurement uncertainty in laboratory reports: A tool for improving the interpretation of test results 153
Monitoring skeletal cancer metastases with the bone isoenzyme of tissue unspecific alkaline phosphatase. 149
Assessment and monitoring of agreement among professionals for morphological evaluation in compliance with International accreditation standard requirements 148
Quality indicators for laboratory diagnostics: consensus is needed. 147
Reference intervals: Are interlaboratory differences appropriate? 145
Evidence on clinical relevance of cardiovascular risk evaluation in the general population using cardio-specific biomarkers 145
Reply to W.G. Wood. Questionable results - who directs the EQAS organisers? Clin Chem Lab Med 2004;42:1073 144
Interpretative comments and reference ranges in EQA programs as a tool for improving laboratory appropriateness and effectiveness 143
IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study 143
External quality assessment for biochemical markers of myocardial damage: an Italian experience. 142
High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapy 142
Quality of plasma samples and BD Vacutainer Barricor tubes: Effects of centrifugation 139
Analytical and clinical performances of a SARS-CoV-2 S-RBD IgG assay: Comparison with neutralization titers 138
Protocollo operativo per la verifica della comparabilità dei risultati di laboratorio ottenuti su più procedure analitiche 135
External Quality Assessment Schemes: need for recognised requirements 131
Defining a roadmap for harmonizing quality indicators in Laboratory Medicine: A consensus statement on behalf of the IFCC Working Group "laboratory Error and Patient Safety" and EFLM Task and Finish Group "performance specifications for the extra-analytical phases" 130
Once upon a time: A tale of ISO 15189 accreditation 130
Risk management in laboratory medicine: quality assurance programs and professional competence. 129
Appropriateness of cholesterol and triglycerides reporting checked by External Quality Assessment programs 129
Performance specifications of critical results management 129
The silk road to total quality in Laboratory Medicine 128
Preanalytical challenges - time for solutions 127
Different approaches for estimating measurement uncertainty: An effective tool for improving interpretation of results 127
Measurement uncertainty: Light in the shadows 127
Evaluation of an ELISA for SARS-CoV-2 antibody testing: Clinical performances and correlation with plaque reduction neutralization titer 127
The use of extra-analytical phase quality indicators by clinical laboratories: The results of an international survey 126
Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays? 125
Quality specifications in EQA schemes: from theory to practice 124
Precipitation method for separating and quantifying bone and liver alkaline phosphatase isoenzymes. 123
Effects of sample transportation on commonly requested laboratory tests. 123
Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy Expert opinion document from the Study Group of Cardiac Biomarkers associated to the Italian Societies ELAS (European Ligand Assay Society, Italy Section), SIBIoC (Società Italiana di Biochimica Clinica), and SIPMeL (Società Italiana di Patologia Clinica e Medicina di Laboratorio) 122
QUALITY INDICATORS IN LABORATORY MEDICINE: THE EXPERIENCE OF A LARGE LABORATORY 119
External quality assessment programs in the context of ISO 15189 accreditation 119
La consulenza del Laboratorio nella gestione del Point Of Care Testing (POCT). 119
Extra-analytical quality indicators and laboratory performances 114
Harmonization of units and reference intervals of plasma proteins: State of the art from an External Quality Assessment Scheme 111
POINT OF CARE TESTING (POCTS): THE IMPORTANCE OF CRITICAL PROBLEMS REPORTING 107
Post-standardization of routine creatinine assays: are they suitable for clinical applications 106
Critical laboratory results: communication is just one of the problems. 104
Serum bone alkaline phosphatase in the follow-up of skeletal metastases. 102
Towards the rational utilization of SARS-CoV-2 serological tests in clinical practice 101
Serological diagnostic for SARS-CoV-2: An experimental External Quality Assessment Scheme 101
Extra-analytical quality indicators - Where to now? 100
Quality Indicators for the Total Testing Process 95
Garantire la comparabilità dei risultati nel rispetto dei requisiti di qualità e delle esigenze organizzative: l’esempio di una procedura operativa 95
APPROPRIATENESS OF CLINICAL REQUEST: IS IT POSSIBLE TO MEASURE IT? 94
Laboratory-related errors: you cannot manage what you don't measure. You manage what you know and measure 94
Importance of control materials in quality assessment of cyclosporine determination. 89
Commutability of external quality assessment materials for point-of-care glucose testing using the Clinical and Laboratory Standards Institute and International Federation of Clinical Chemistry approaches 87
IFCC project “Model of quality indicators”: a method for results evaluation 86
Innovative software for recording preanalytical errors in accord with the IFCC quality indicators 86
The standardization of plasma protein checked by an external quality assessment scheme (EQAS) 83
Quality indicators to detect pre-analytical errors: a lighthouse in the night. 79
Multicentric evaluation of the variability of digital morphology performances also respect to the reference methods by optical microscopy 73
Pre-analytical quality indicators in laboratory medicine: Performance of laboratories participating in the IFCC working group “Laboratory Errors and Patient Safety” project 68
Totale 10.450
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.739
article - articoli 28.589
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.328
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021647 0 0 0 0 33 80 39 72 133 52 82 156
2021/20221.067 57 101 158 67 23 85 59 109 45 40 110 213
2022/2023693 149 49 31 47 115 66 17 60 80 24 38 17
2023/2024474 26 41 45 45 37 30 63 22 27 17 55 66
2024/20251.639 16 106 70 79 213 34 118 113 135 68 288 399
2025/20263.421 227 564 938 1.123 569 0 0 0 0 0 0 0
Totale 10.450